PASG
Passage BIO, Inc.
Next earnings Aug 10, 2026 · consensus $-2.85 EPS
$4.33
▼ -26.36%$4.33▼ -44.63%
over 1Y
L $4.08EODHDH $19.85
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-26.4%
1W-22.5%
1M-22.0%
3M-37.2%
YTD-63.0%
1Y-44.6%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Mixed signals in the latest filings.
Passage BIO, Inc. shows limited reported revenue, and -242.7% ROE.
Sources: SEC EDGAR (CIK 0001787297, latest 10-Q filed 2026-05-12) · EODHD · as of 6/23/2026, 12:10:41 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.